Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis

Basit Öğe Kaydı
dc.authoridAyça Bal Öztürk / 0000-0002-6502-528Xen_US
dc.authorscopusidAyça Bal Öztürk / 57062000100
dc.authorwosidAyça Bal Öztürk / M-4472-2018
dc.contributor.authorAlarçin, Emine
dc.contributor.authorDemirbağ, Çağlar
dc.contributor.authorKarslı Ceppioğlu, Seher
dc.contributor.authorKerinnoğlu, Oya
dc.contributor.authorBal Öztürk, Ayça
dc.date.accessioned2020-08-30T20:06:18Z
dc.date.available2020-08-30T20:06:18Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Temel Bilimleri Bölümüen_US
dc.description.abstractOxaceprol is well-defined therapeutic agent as an atypical inhibitor of inflammation in osteoarthritis. In the present study, we aimed to develop and characterize oxaceprol-loaded poly-lactide-co-glycolide (PLGA) nanoparticles for intra-articular administration in osteoarthritis. PLGA nanoparticles were prepared by double-emulsion solvent evaporation method. Meanwhile, a straightforward and generally applicable high performance liquid chromatography method was developed, and validated for the first time for the quantification of oxaceprol. To examine the drug carrying capacity of nanoparticles, varying amount of oxaceprol was entrapped into a constant amount of polymer matrix. Moreover, the efficacy of drug amount on nanoparticle characteristics such as particle size, zeta potential, morphology, drug entrapment, and in vitro drug release was investigated. Nanoparticle sizes were between 229 and 509 nm for different amount of oxaceprol with spherical smooth morphology. Encapsulation efficiency ranged between 39.73 and 63.83% by decreasing oxaceprol amount. The results of Fourier transform infrared and DSC showed absence of interaction between oxaceprol and PLGA. The in vitro drug release from these nanoparticles showed a sustained release of oxaceprol over 30 days. According to cell culture studies, oxaceprol-loaded nanoparticles had no cytotoxicity with high biocompatibility. This study was the first step of developing an intra-articular system in the treatment of osteoarthritis for the controlled release of oxaceprol. Our findings showed that these nanoparticles can be beneficial for an effective treatment of osteoarthritis avoiding side effects associated with oral administration.en_US
dc.description.sponsorshipMarmara University Scientific Research Projects Coordination UnitMarmara University [SAG-A-120613-0234]en_US
dc.description.sponsorshipMarmara University Scientific Research Projects Coordination Unit, Grant/Award Number: SAG-A-120613-0234en_US
dc.identifier.citationAlarçin, E., Demirbağ, Ç., Karsli‐Ceppioglu, S., Kerimoğlu, O., & Bal‐Ozturk, A. (2020). Development and characterization of oxaceprol‐loaded poly‐lactide‐co‐glycolide nanoparticles for the treatment of osteoarthritis. Drug Development Research, 81(4), 501-510.en_US
dc.identifier.doi10.1002/ddr.21642en_US
dc.identifier.endpage510en_US
dc.identifier.issn0272-4391en_US
dc.identifier.issn1098-2299en_US
dc.identifier.issue4en_US
dc.identifier.pmid31958153en_US
dc.identifier.scopus2-s2.0-85078678014en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage501en_US
dc.identifier.urihttps://doi.org/10.1002/ddr.21642
dc.identifier.urihttps://hdl.handle.net/20.500.12713/461
dc.identifier.volume81en_US
dc.identifier.wosWOS:000508046800001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorBal Öztürk, Ayçaen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofDrug Development Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIntra-Articular Injectionen_US
dc.subjectNanoparticleen_US
dc.subjectOsteoarthritisen_US
dc.subjectOxaceprolen_US
dc.subjectPlgaen_US
dc.titleDevelopment and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritisen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
92.pdf
Boyut:
2.95 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Eczacılık Temel Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu